Maurizio Recanatini - Concepedia

Author

Maurizio Recanatini

University of Bologna ORCID

Also Known As

M Recanatini, M. RECANATINI, M. Recanatini, Maurizio Recanatini, Recanatini, M., Recanatini, Maurizio

236

Publications

9.5K

Citations

H-Index

154

Concepts

All Affiliations

University of Bologna Italian Institute of Technology Saarland University University of Ferrara

About

Maurizio Recanatini is an author at University of Bologna specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	59	3.2K
2	Natural Sciences	29	45	2K
3	Engineering	12	13	457
4	Social Sciences	2	2	188
5	Applied Physics	2	2	36

Maurizio Recanatini

119

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Toward a Pharmacophore for Drugs Inducing the Long QT Syndrome: Insights from a CoMFA Study of HERG K<sup>+</sup> Channel Blockers Andrea Cavalli, Elisabetta Poluzzi, Fabrizio De Ponti, Journal of Medicinal Chemistry Molecular PharmacologyChannelopathiesLong Qt SyndromeSignal TransductionHerg Blocking Potency	2002	383
3-(4-{[Benzyl(methyl)amino]methyl}phenyl)-6,7-dimethoxy-2<i>H</i>-2-chromenone (AP2238) Inhibits Both Acetylcholinesterase and Acetylcholinesterase-Induced β-Amyloid Aggregation: A Dual Function Lead for Alzheimer's Disease Therapy Lorna Piazzi, Angela Rampa, Alessandra Bisi, Journal of Medicinal Chemistry	2003	263
Multi-Target-Directed Drug Design Strategy: From a Dual Binding Site Acetylcholinesterase Inhibitor to a Trifunctional Compound against Alzheimer’s Disease María Laura Bolognesi, Andrea Cavalli, Luca Valgimigli, Journal of Medicinal Chemistry	2007	254
Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds Lorna Piazzi, Andrea Cavalli, Francesco Colizzi, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryNeurodegenerative DiseasesAlzheimer's DiseaseBace1 InhibitorsMedicine	2007	211
Galloflavin (CAS 568‐80‐9): A Novel Inhibitor of Lactate Dehydrogenase Marcella Manerba, Marina Vettraino, L. Fiume, ChemMedChem Molecular PharmacologyMetabolic PathwaysGlycolysis InhibitorsCellular EnzymologyBiochemistry	2011	190
Single-Molecule Pulling Simulations Can Discern Active from Inactive Enzyme Inhibitors Francesco Colizzi, Remo Perozzo, Léonardo Scapozza, Journal of the American Chemical Society	2010	180
A Small Molecule Targeting the Multifactorial Nature of Alzheimer's Disease Andrea Cavalli, María Laura Bolognesi, Simona Capsoni, Angewandte Chemie International Edition Amyloid βMolecular BiologyNeurochemical BiomarkersReactive Oxygen SpeciesSmall Molecules	2007	178
SAR of 9-Amino-1,2,3,4-tetrahydroacridine-Based Acetylcholinesterase Inhibitors: Synthesis, Enzyme Inhibitory Activity, QSAR, and Structure-Based CoMFA of Tacrine Analogues Maurizio Recanatini, Andrea Cavalli, Federica Belluti, Journal of Medicinal Chemistry	2000	154
Determination of lipophilicity by means of reversed-phase thin-layer chromatography G. Biagi, Anna Barbaro, Andrea Sapone, Journal of Chromatography A Lipid AnalysisDrug AnalysisMedicineAnalytical ChemistryLiquid Chromatography	1994	136
Protein Conformational Transitions: The Closure Mechanism of a Kinase Explored by Atomistic Simulations Anna Berteotti, Andrea Cavalli, Davide Branduardi, Journal of the American Chemical Society	2008	132

Page 1